These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 22161689

  • 1. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
    Rutkowski R, Mertens-Walker I, Lisle JE, Herington AC, Stephenson SA.
    Int J Cancer; 2012 Sep 01; 131(5):E614-24. PubMed ID: 22161689
    [Abstract] [Full Text] [Related]

  • 2. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.
    Proc Natl Acad Sci U S A; 2004 Apr 13; 101(15):5583-8. PubMed ID: 15067119
    [Abstract] [Full Text] [Related]

  • 3. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK, Yang NY, Silldorff M, Mutyala R, Pasquale EB.
    Biochem J; 2009 Aug 27; 422(3):433-42. PubMed ID: 19552627
    [Abstract] [Full Text] [Related]

  • 4. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A, Broggini T, Harms C, Adams RH, Vajkoczy P, Czabanka M.
    Int J Mol Sci; 2021 Jul 27; 22(15):. PubMed ID: 34360793
    [Abstract] [Full Text] [Related]

  • 5. Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.
    Kawahara Y, Furuta T, Sabit H, Tamai S, Dong Y, Jiapaer S, Zhang J, Zhang G, Oishi M, Miyashita K, Hayashi Y, Nakada M.
    Cancer Lett; 2019 May 01; 449():56-65. PubMed ID: 30776480
    [Abstract] [Full Text] [Related]

  • 6. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK, Foos G, Hauser CA, Pasquale EB.
    Nat Cell Biol; 2006 Aug 01; 8(8):815-25. PubMed ID: 16862147
    [Abstract] [Full Text] [Related]

  • 7. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
    Lisle JE, Mertens-Walker I, Stephens CR, Stansfield SH, Clements JA, Herington AC, Stephenson SA.
    Exp Cell Res; 2015 Apr 10; 333(1):136-46. PubMed ID: 25724897
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
    Bhatia S, Oweida A, Lennon S, Darragh LB, Milner D, Phan AV, Mueller AC, Van Court B, Raben D, Serkova NJ, Wang XJ, Jimeno A, Clambey ET, Pasquale EB, Karam SD.
    Cancer Res; 2019 May 15; 79(10):2722-2735. PubMed ID: 30894369
    [Abstract] [Full Text] [Related]

  • 9. Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.
    Ozgür E, Heidenreich A, Dagtekin O, Engelmann U, Bloch W.
    Urol Oncol; 2011 May 15; 29(1):78-84. PubMed ID: 19272799
    [Abstract] [Full Text] [Related]

  • 10. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.
    Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS.
    Am J Pathol; 2006 Jul 15; 169(1):279-93. PubMed ID: 16816380
    [Abstract] [Full Text] [Related]

  • 11. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM, Arthur A, Hayball JD, Gronthos S.
    Stem Cells Dev; 2013 Oct 15; 22(20):2751-64. PubMed ID: 23711177
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
    Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M.
    Dev Biol; 2004 Jul 15; 271(2):263-71. PubMed ID: 15223333
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development.
    Chennakesava CS, Di Santo S, Ziemiecki A, Schneider H, Andres AC.
    Placenta; 2006 Jul 15; 27(9-10):959-67. PubMed ID: 16343615
    [Abstract] [Full Text] [Related]

  • 20. PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.
    Aslam MI, Abraham J, Mansoor A, Druker BJ, Tyner JW, Keller C.
    Proc Natl Acad Sci U S A; 2014 Apr 29; 111(17):6383-8. PubMed ID: 24733895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.